TMS or Transcranial Magnetic Stimulation, a treatment method used globally for depression, OCD, migraines and other conditions, is described as “non-invasive brain stimulation.

Pedigree Technologies has announced an integration with Carrier Logistics that embeds driver communications, ...

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system (CNS) disorders, ...

ATLANTA, GA, UNITED STATES, January 29, 2026 /EINPresswire.com/ -- CSCS, a provider of an Agentic AI-powered supply ...

The global medical cyclotron market shows steady growth, expected to be valued at around US$246.8 million in 2026 and projected to reach US$405.4 million by 2033, with a CAGR of 5.4% during this ...

The International Association of Top Professionals (IAOTP) will honor Dr. Romena Kiryakous at their annual awards gala ...

LONG BEACH, CA - February 06, 2026 - PRESSADVANTAGE - A newly published educational resource provides an in-depth, ...

Jeffrey Epstein discussed an alleged short-term memory erasing technology with a former senior MIT figure in a 2014 email., US News, Times Now ...

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

QuantalX combined transcranial magnetic stimulation and EEG technology in its first-of-its-kind brain network function ...

–Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept (“POC”) Study in Treatment Resistant Depression (“TRD”) in the Second Half of 2026– ...

As Valentine’s Day gifting trends continue to shift toward wellness-focused products, neuromodulation devices are emerging as a category of interest. VILNIUS ...